US20060178719A1 - Method and apparatus for passive cardiac stimulation - Google Patents

Method and apparatus for passive cardiac stimulation Download PDF

Info

Publication number
US20060178719A1
US20060178719A1 US11/391,604 US39160406A US2006178719A1 US 20060178719 A1 US20060178719 A1 US 20060178719A1 US 39160406 A US39160406 A US 39160406A US 2006178719 A1 US2006178719 A1 US 2006178719A1
Authority
US
United States
Prior art keywords
heart
conductive element
conductor assembly
stimulus
conductor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/391,604
Inventor
Raymond Ideker
Steven Girouard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/008695 external-priority patent/WO2000057950A1/en
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Priority to US11/391,604 priority Critical patent/US20060178719A1/en
Assigned to THE UAB RESEARCH FOUNDATION reassignment THE UAB RESEARCH FOUNDATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GIROUARD, STEVEN D., IDEKER, RAYMOND E.
Publication of US20060178719A1 publication Critical patent/US20060178719A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36114Cardiac control, e.g. by vagal stimulation

Definitions

  • the subject invention relates to a method and apparatus for cardiac stimulation.
  • the subject invention provides a passive conductor for use in combination with an implanted stimulating device for passively stimulating remote regions of the heart and a method of using same.
  • Typical implanted devices include defibrillators and/or pacemakers. These types of devices are usually surgically implanted into a subject and an intracavitary electrode is placed within or adjacent to the heart, typically transvenously.
  • implanted stimulating devices competently carry out their design task
  • locations such as, but not limited to, the left ventricular apex, the anterior-basal left ventricular free wall, and the left atrium near the pulmonary veins.
  • multi-site pacing for congestive heart failure
  • single or multi-site pacing to prevent a ventricular or atrial tachyrhythmia
  • single or multi-site pacing very soon after the onset of an arrhythmia to halt the arrhythmia before it degenerates into ventricular or atrial fibrillation requiring a defibrillation shock
  • multi-site electrodes for delivery of shocks with a lower defibrillation threshold than shocks delivered only through transvenous electrodes.
  • Electrodes on catheters inserted into veins of the heart by way of the coronary sinus can be placed in many cardiac locations, there are a number of spots or locations to which they cannot reach or be placed. Electrodes can be placed in almost any desired epicardial location during open-heart surgery. However, such surgery is expensive and is associated with both mortality and morbidity of the subject. With the advent of thoracoscopic surgery, it is now possible to implant such electrodes in the pericardial space by a much more minor procedure that requires only one or two small incisions for the insertion of a thoracoscopic device. However, this type of procedure is still complicated by the fact that the electrodes still must be connected to wires that are tunneled through the body to the pacemaker or defibrillator.
  • an apparatus and method for stimulating portions of the heart which are difficult or impossible to reach or stimulate with a transvenous electrode but which are accessible utilizing the less invasive thoracoscopic surgical technique and which is able to stimulate the remote regions of the heart without the necessity for tunneling wires through a body of the subject and connection to a pacemaker or defibrillator for a source of electrical stimuli.
  • a passive conductor assembly for use with an implanted stimulating device having an intracavitarily or transvenously disposed electrode is disclosed.
  • the passive conductor assembly for use in combination with the implanted stimulus generator having an intracavitarily or intravenously disposed electrode includes at least one conductive element having a first end and a second end, and/or other contact sites for contacting a desired or selected portion of a heart of a subject to be stimulated.
  • the passive conductor assembly is disposed in proximity to the intracavitarily or transvenous electrode which is connected to the implanted stimulus generator such as a pacemaker or defibrillator.
  • the passive conductor assembly can include electrical components disposed in electrical communication therewith to provide for the manipulation and/or modification of the electrical stimulus or waveform generated by the implanted stimulus generator which can be designed, for example, to selectively stimulate only neural tissue and not cardiac tissue or vice versa through the same passive conductor assembly.
  • FIG. 1 illustrates the potential field from a 500-V 6 ms unsuccessful defibrillation shock.
  • the top two panels represent the subepicardial potentials, and the bottom two panels represent the subendocardial potentials. All panels show the potentials superimposed on the epicardial surface of the heart.
  • the two panels on the left represent the left antero-lateral view of the heart, whereas the two panels on the right represent the right postero-lateral view of the heart. Numbers denote the location of the recording electrodes and the potential in volts recorded at each site. Isopotential lines are separated by 25V. Solid circles represent locations where good recordings were not obtained.
  • the dashed line indicates the upper border of the right ventricular outflow tract.
  • the present invention provides for a passive conductor assembly used in combination with an implanted cardiac stimulation device or generator such as a pacemaker or a defibrillator having an intracavitarily or intravenously disposed electrode.
  • the passive conductor assembly can be placed by surgery or thoracoscopy to electrically stimulate the heart of a subject which does not require the running or tunneling of wires from the passive conductor assembly to the implanted stimulus generator. That is, the passive conductor assembly can be completely self-contained or disposed completely within the pericardial space of the heart and used in conjunction with a defibrillator or a pacemaker connected to leads or electrodes that are inserted into the heart.
  • the passive conductor assembly includes at least one conductive element having a first end, a second end, and/or other contact sites for contacting a portion of the heart of the subject.
  • the conductive element is preferably comprised of a low-resistance material and can have any suitable length but typically ranges from approximately 1 cm to approximately 12 cm.
  • the conductive element can be made of any conductive material but is preferably constructed of a metallic material in the form of wire or strips that are placed in the pericardial space and contact the heart. Additionally, the conductive element can be constructed of a composite ribbon of conductive material.
  • the conductive elements can be exposed to the heart along their entire length forming a single electrode, however, in a preferred embodiment, the conductive element is insulated along most of its length except at the two ends or other intermediate sites which form the electrodes or contact sites.
  • the insulator can comprise any suitable electrically insulative material that is also biocompatible.
  • the insulation can be removed at one or more additional locations along the conductive elements to stimulate additional sites of the heart.
  • the ends of the conductive element should be placed at the points on the heart at which the electrical stimulus or waveform delivered by the pacemaker or the defibrillator, through their own transvenous electrode, creates a potential differential on the surface of the heart to facilitate the flow of the electrical stimulus. That is, if the two ends of the conductive element are placed at sites that have approximately the same electrical potential, little or no current will flow therethrough.
  • electrical components can be disposed in electrical communication with or along the conductive element.
  • These electrical components can include, for example, diodes, devices capable of storing energy such as capacitors, microprocessors, resistors, and the like.
  • the electrical components can also be used in combinations such that the passive conductor can act as a low-pass or high-pass filter to modify the input stimulus or waveform from the implanted stimulus generator.
  • a diode could be placed along the conductive element such that the stimulus or electrical current could only flow in one direction along the conductive element during the stimulation.
  • This embodiment has several advantages, for example, it becomes possible to pace from some sites in the heart but not others by controlling which polarity of stimulus was generated by the implanted stimulus generator through its electrode(s). If two or more conductors are utilized, then the diode could be oriented in one direction for some of the electrodes and oriented in the opposite direction for other of the electrodes so that the first set of electrodes would pass current with one polarity while the other set would pass current of the other polarity. An additional set of conductors could contain no diode such that they would pass current with either polarity.
  • the use of electrical components disposed along the conductive element increases the flexibility of stimulating of myocardium in different combinations and in different sequences.
  • Diodes may also be useful for delivering defibrillation and cardioversion shocks.
  • most defibrillation shocks are biphasic with a second phase opposite in polarity to the first phase. The presence of the diode in one or more of the conductive elements would allow current to flow during one phase but not the other phase of the biphasic waveform. Therefore, the region of low field strength would only be present during one of the two phases of the shock so that the area could receive a stronger defibrillating field strength during the other phase.
  • a capacitor is utilized instead of a diode along the length of the conductive element.
  • the capacitor would allow current to flow during the early portion of the shock pulse thereby creating the low field strength region, but would not allow much current to flow later during the pulse, at which time the low field strength region would no longer be of the same strength and location.
  • the capacitor Towards the end of the shock pulse and after the shock pulse, the capacitor would discharge, creating a biphasic shock effect in some portions of the heart.
  • the second phase could be delivered either immediately after the first phase or after an interval of up to 5 ms or more since it has been shown that such a separation does not significantly decrease the beneficial effects of a biphasic pulse on defibrillation.
  • the capacitor would discharge during the second phase either partially or entirely followed by charging in the opposite polarity toward the end of the second phase. This interaction would change the ratio of the currents passing through the passive conductor assembly and through the active intravascular defibrillation electrodes throughout the pulses. Accordingly, the size and location of the low field regions should change throughout the pulses instead being fixed in one region. The movement of this low field strength region should have a beneficial effect on the defibrillation threshold.
  • the two active phases of the shock could be separated by up to 5 or more ms so that the capacitor will largely discharge between the two phases and following the second active phase.
  • Biphasic pulses are frequently used for pacing to prevent electrolysis and the plating or the unplating of the pacing electrodes that can occur with a single polarity pulse. Disposing a capacitor along the length of the conductor would generate a biphasic pacing pulse since it allows only a zero net charge to pass through the conductor after it has been discharged.
  • Other electronic components used in combination with the passive conductor assembly could be useful. These components could be powered by the current that passes through the conductive element when a stimulus is delivered through the active intravascular electrodes of the pacemaker or defibrillator. Electronic components could store the charge to power the other components disposed along the conductive element for some period of time following pulses delivered by the pacemaker or the defibrillator. The pulses to charge these electronic components could either be delivered whenever needed to treat or prevent arrhythmias or the pacemaker or defibrillator could deliver a small stimulus at specific time intervals for the sole purpose of charging the components disposed along the conductive element. This small stimulus could be of a frequency that does not stimulate the myocardium.
  • the electronic components that are powered along the conductive elements could perform several functions, for example, sensing activations at the ends or contacts on the conductive element. Pacing stimuli or shocks at these points along the conductive element could be time-based on the recorded activations from these electrodes. The timing algorithms could be performed by the electronic components disposed along the conductive element. Alternatively, the power in the conductive element could be used to pass a signal to the pacemaker or the defibrillator or its recording electrodes so that the software within the pacemaker or the defibrillator could control and integrate the responses of all of the passive conductors. Communication signals between the components disposed along the conductive element of the passive conductor and the pacemaker or the defibrillator could be by any modality including electrical or optical. If electrical, the frequency and strength of the signal could be such that the signal does not cause stimulation of the heart.
  • the passive conductor assembly is preferably oriented so that, during an electrical pulse delivered by the separated implanted stimulus generator, a potential difference is generated between the ends or other exposed regions (electrodes) of the conductive element disposed in the pericardial space.
  • electrodes Electrodes
  • at least one of the electrodes will be placed on the epicardium overlying one of the implanted stimulus generator leads or electrodes located within the cavities of the heart or veins.
  • other orientations may also be useful.
  • the present invention provides a method and device for the stimulation or the inhibition of neural inputs to the heart with the purpose of preventing atrial or ventricular arrhythmias, terminating atrial or ventricular arrhythmias, assisting in atrial or ventricular defibrillation, control of heart-rate variability, or the improvement of cardiac function.
  • the passive electrical components By adding the passive electrical components to the passive conductive element and modulating the frequency of stimulation of the intracavitary electrode therewith, the present invention allows for selective stimulation and/or inhibition of neural tissue and not cardiac tissue or vice versa through the same passive conductor assembly.
  • the device for the extra-cardiac stimulation or inhibition of neural inputs to the heart is similar if not identical to the device described immediately above.
  • the uninsulated portions (electrodes) of at least one conductive element are disposed in contact with the heart and/or other tissues such as neural tissue, fat pads containing post-ganglionic neural fibers, cardiac veins adjacent to neural fibers, or other electrically excitable tissues such as the stellate ganglia and the vagus.
  • the conductive element can also run circumferentially along the atrial-ventricular groove of the heart such that the sympathic and the parasymphatic innervation, running parallel to cardiac vasculature, can be directly stimulated or inhibited.
  • the electrical stimulation or inhibition will be achieved with the application of stimuli from approximately 1 to 20 mA at a frequency of approximately 1 to 50 Hz.
  • the stimulus could have a pulse width from approximately 10-250 ⁇ sec, a current of approximately 1-20 mA, and a frequency of approximately 1-50 Hz.
  • the stimulus could have a pulse width from approximately 0.5-2 msec, a current of approximately 1-20 mA and a frequency of approximately 1-5 Hz.
  • the conductive element should be oriented such that when an electrical stimulus or pulse is delivered from the implanted stimulus generator, an electrical potential difference will be created on the epicardial surface between the two or more exposed electrodes on the conductive element. As a result of this potential difference, current will be induced to flow in the conductive element.
  • at least one conductive element should be placed in close proximity to the cardiac tissue overlying either an intracavitary electrode in an atrial or ventricular chamber, cardiac vein, or other location in or near the heart.
  • the passive conductor assembly having at least one conductive element may be placed in the pericardial space, an extra-pericardial space, or in other extra-cardiac locations.
  • the passive conductor assembly can be placed during surgery that exposes these locations directly or may be placed using minimally invasive techniques such as thoracoscopic surgery, or transvenously through an introducing catheter.
  • passive conductor assemblies for both neural stimulation/inhibition can be combined with passive conductor assemblies for directly exciting cardiac tissue.
  • the largest effect utilizing the passive conductor assembly of the present invention is generally seen when one end of the conductive element is placed directly on the epicardium over the intravenous electrode of the stimulus generating device. However, this does not have to be the case.
  • the implanted stimulus generator should cause hyperpolarization at one end and depolarization at the other. Accordingly, it should be possible to place the passive conductor assembly in a region that is normally undergoing depolarization induced by the stimulus.
  • more than one passive conductor assembly can be used in the same subject.
  • arrhythmias may be prevented by simultaneously stimulating from several sites on the heart.
  • Two, three, or even more of the passive conductor assemblies could be placed in the pericardial space to pace from all of the sites.
  • the stimulus strength will be larger than if it was directly paced at each of the sites with electrodes connected directly to the implanted stimulus generator, the strength of the electrical stimulus should still be smaller than that required to directly activate all of these regions by a stimulus from the transvenous electrodes in the absence of the passive conductors of the present invention.
  • the passive conductor assembly of the present invention can be used for prevention and treatment of atrial-arrhythmias, ventricular arrhythmias, as well as for the control of cardiac performance through control of heart rate and atrial and ventricular refractory periods. Additionally, the passive conductor assembly can be used for the control of heart rate through stimulation of neural inputs to the sino-atrial and atrial-ventricular nodes of the heart.
  • the passive conductor assembly of the present invention may be useful for augmenting traditional therapies such as antitachycardia pacing by altering the excitable gap through neural stimulation, thus improving the probability of pace termination of arrhythmias.
  • the passive conductor assembly and method for use thereof for neural stimulation may be beneficial for lowering the energy requirements for electrical termination of atrial or ventricular fibrillation.
  • Neural stimulation can slow or even halt impulse propagation from the atria to the ventricles.
  • the passive conductor assembly of the present invention should allow for control of the ventricular response to premature atrial contractions by slowing or stopping impulse propagation at the atrial-ventricular node.
  • supra-ventricular arrhythmias such as Wolf-Parkinson-White Syndrome, atrial-ventricular nodal re-entrant tachycardia, atrial fibrillation or atrial flutter with rapid ventricular response and other arrhythmias may be successfully prevented, terminated, or controlled.
  • compositions and methods according to the present invention are shown below in the Example section.
  • FIG. 1 illustrates the distribution of potentials generated with electrodes in the right ventricular cavity and on the skin of the left lower thorax. Even though the potential did change rapidly with distance in the lateral-apical left ventricle in the region marked A, signifying the potential gradient as low, the potential in this region for a 500V defibrillation shock was 83V more than the value on the epicardium overlying the electrode in the right ventricle in the region marked B [ ⁇ 48V ⁇ ) ⁇ 131 V)]. If a wire was attached to the epicardium at these spots, current should flow through the wire and the potential gradient should be increased in the lateral-apical left ventricle. This should allow stimulation of the tissue in the lateral-apical left ventricle region with a much weaker stimulus than required in the absence of the wire.
  • an electric wire 100 has one end 102 both electrically and mechanically attached to a preselected region 104 of the heart, e.g. by suturing.
  • a second end 106 of the wire 100 is both electrically and mechanically connected to a different region 108 of the heart, also preferably by suturing. Since the heart regions 104 and 108 of the heart attain different electric potentials during cardiac contraction, current flows through the wire thus achieving passive stimulation of the myocardium.
  • the wire 100 is electrically insulated in any conventional fashion between its ends 102 and 106 . However, one or more points of the wire 100 between its ends may be electrically connected to the heart to provide passive stimulation during cardiac contraction.
  • the area near the pulmonary veins appears to frequently play a role in the induction and/or maintenance of atrial fibrillation. This is also the region in which the effect of the shock is weakest for electrodes in the right atrium and the distal coronary sinus as shown by Cooper et al. (Herzschr Elektrophys, 1998; 9:1-7). It should be possible to run a conductor to this region by way of the transverse sinus in the pericardial space. Such an electrode location should be beneficial for pacing to prevent atrial fibrillation, for giving a small pacing or shocking stimulus or stimuli just as atrial fibrillation begins, or for giving a defibrillation shock to halt atrial fibrillation once it is established.

Abstract

A passive conductor assembly for use with an implanted stimulating device having an intracavitarily or transvenously disposed electrode is disclosed. The passive conductor assembly used in combination with the implanted stimulus generator having an intracavitarily or intravenously disposed electrode includes at least one conductive element having a first end and a second end, and/or other contacting sites for contacting a portion of a heart of a subject to be stimulated. The passive conductor is disposed in proximity to the intracavitarily or transvenous electrode which is connected to the implanted stimulus generator such as a pacemaker or defibrillator. Upon discharge of an electrical stimulus or waveform from the implanted stimulus generator, the stimulus is conducted through the myocardial tissue to the conductor assembly where it is passively conducted to a region of the heart in contact with an end or other contacting sites of the conductive element of the passive conductor assembly which have been selected for cardiac stimulation. The passive conductor assembly can include electrical components disposed in electrical communication therewith which provide for the manipulation and/or modification of the electrical stimulus or waveform generated by the implanted stimulus generator which can be designed, for example, to selectively stimulate only neural tissue and not cardiac tissue or vice versa through the same passive conductor assembly.

Description

    TECHNICAL FIELD
  • The subject invention relates to a method and apparatus for cardiac stimulation. In particular, the subject invention provides a passive conductor for use in combination with an implanted stimulating device for passively stimulating remote regions of the heart and a method of using same.
  • BACKGROUND OF THE INVENTION
  • By way of background, the application of electrical current to the heart through electrodes either applied directly to the chest or through an implanted device is well known in the art. Typical implanted devices include defibrillators and/or pacemakers. These types of devices are usually surgically implanted into a subject and an intracavitary electrode is placed within or adjacent to the heart, typically transvenously.
  • While these implanted stimulating devices competently carry out their design task, there are many instances in which it would be desirable to electrically stimulate a portion of the heart that is either difficult to reach with a transvenously disposed electrode or which has been previously connected to an implanted electrode. For example, locations such as, but not limited to, the left ventricular apex, the anterior-basal left ventricular free wall, and the left atrium near the pulmonary veins. It may be necessary and advantageous to electrically stimulate the heart from these regions for reasons including multi-site pacing for congestive heart failure, single or multi-site pacing to prevent a ventricular or atrial tachyrhythmia, single or multi-site pacing very soon after the onset of an arrhythmia to halt the arrhythmia before it degenerates into ventricular or atrial fibrillation requiring a defibrillation shock, and multi-site electrodes for delivery of shocks with a lower defibrillation threshold than shocks delivered only through transvenous electrodes.
  • While electrodes on catheters inserted into veins of the heart by way of the coronary sinus can be placed in many cardiac locations, there are a number of spots or locations to which they cannot reach or be placed. Electrodes can be placed in almost any desired epicardial location during open-heart surgery. However, such surgery is expensive and is associated with both mortality and morbidity of the subject. With the advent of thoracoscopic surgery, it is now possible to implant such electrodes in the pericardial space by a much more minor procedure that requires only one or two small incisions for the insertion of a thoracoscopic device. However, this type of procedure is still complicated by the fact that the electrodes still must be connected to wires that are tunneled through the body to the pacemaker or defibrillator.
  • It has been recognized that the heart is under profound control of the autonomic nervous system. There are many instances when electrical stimulation of the neural input to the heart could be beneficial for the alteration of cardiac electrophysiologic status. The difficulty in implementing neural stimulation of the heart has been in the development of an apparatus for the direct stimulation or inhibition of cardiac sympathetic and parasympathetic nerves.
  • Accordingly, it would be advantageous and desirable to have an apparatus and method for stimulating portions of the heart which are difficult or impossible to reach or stimulate with a transvenous electrode but which are accessible utilizing the less invasive thoracoscopic surgical technique and which is able to stimulate the remote regions of the heart without the necessity for tunneling wires through a body of the subject and connection to a pacemaker or defibrillator for a source of electrical stimuli.
  • Furthermore, it would also be advantageous and desirable to have a method and apparatus which allows for the selective stimulation of the heart.
  • SUMMARY OF THE INVENTION
  • A passive conductor assembly for use with an implanted stimulating device having an intracavitarily or transvenously disposed electrode is disclosed. The passive conductor assembly for use in combination with the implanted stimulus generator having an intracavitarily or intravenously disposed electrode includes at least one conductive element having a first end and a second end, and/or other contact sites for contacting a desired or selected portion of a heart of a subject to be stimulated. The passive conductor assembly is disposed in proximity to the intracavitarily or transvenous electrode which is connected to the implanted stimulus generator such as a pacemaker or defibrillator. Upon discharge of an electrical stimulus or waveform from the implanted stimulus generator, the stimulus is conducted through the myocardial tissue to the conductor where it is passively conducted to a region of the heart in contact with an end or other contact sites of the conductive element of the passive conductor assembly which have been selected for cardiac stimulation.
  • The passive conductor assembly can include electrical components disposed in electrical communication therewith to provide for the manipulation and/or modification of the electrical stimulus or waveform generated by the implanted stimulus generator which can be designed, for example, to selectively stimulate only neural tissue and not cardiac tissue or vice versa through the same passive conductor assembly.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The following detailed description is best understood with reference to the following drawings in which:
  • FIG. 1 illustrates the potential field from a 500-V 6 ms unsuccessful defibrillation shock. The top two panels represent the subepicardial potentials, and the bottom two panels represent the subendocardial potentials. All panels show the potentials superimposed on the epicardial surface of the heart. The two panels on the left represent the left antero-lateral view of the heart, whereas the two panels on the right represent the right postero-lateral view of the heart. Numbers denote the location of the recording electrodes and the potential in volts recorded at each site. Isopotential lines are separated by 25V. Solid circles represent locations where good recordings were not obtained. The dashed line indicates the upper border of the right ventricular outflow tract. LV=left ventricle; RV=right ventricle; RVOT=right ventricular outflow tract; LAD=left anterior descending coronary artery; RCA=right coronary artery; Cx=circumflex coronary artery.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention provides for a passive conductor assembly used in combination with an implanted cardiac stimulation device or generator such as a pacemaker or a defibrillator having an intracavitarily or intravenously disposed electrode. The passive conductor assembly can be placed by surgery or thoracoscopy to electrically stimulate the heart of a subject which does not require the running or tunneling of wires from the passive conductor assembly to the implanted stimulus generator. That is, the passive conductor assembly can be completely self-contained or disposed completely within the pericardial space of the heart and used in conjunction with a defibrillator or a pacemaker connected to leads or electrodes that are inserted into the heart.
  • The passive conductor assembly includes at least one conductive element having a first end, a second end, and/or other contact sites for contacting a portion of the heart of the subject. The conductive element is preferably comprised of a low-resistance material and can have any suitable length but typically ranges from approximately 1 cm to approximately 12 cm. The conductive element can be made of any conductive material but is preferably constructed of a metallic material in the form of wire or strips that are placed in the pericardial space and contact the heart. Additionally, the conductive element can be constructed of a composite ribbon of conductive material. The conductive elements can be exposed to the heart along their entire length forming a single electrode, however, in a preferred embodiment, the conductive element is insulated along most of its length except at the two ends or other intermediate sites which form the electrodes or contact sites.
  • The insulator can comprise any suitable electrically insulative material that is also biocompatible. In a further embodiment, the insulation can be removed at one or more additional locations along the conductive elements to stimulate additional sites of the heart.
  • The ends of the conductive element should be placed at the points on the heart at which the electrical stimulus or waveform delivered by the pacemaker or the defibrillator, through their own transvenous electrode, creates a potential differential on the surface of the heart to facilitate the flow of the electrical stimulus. That is, if the two ends of the conductive element are placed at sites that have approximately the same electrical potential, little or no current will flow therethrough.
  • The exposed portions (ends and/or regions therebetween) of the conductive element in the contact with the heart can vary in size depending on the current density and the potential gradient in the immediately adjacent tissue. Typically, the contact portion of the conductive element can range from approximately 0.2 mm to 4 cm.
  • In order to modify the electrical stimulus or waveform received from the implanted stimulus generator, electrical components can be disposed in electrical communication with or along the conductive element. These electrical components can include, for example, diodes, devices capable of storing energy such as capacitors, microprocessors, resistors, and the like. The electrical components can also be used in combinations such that the passive conductor can act as a low-pass or high-pass filter to modify the input stimulus or waveform from the implanted stimulus generator. In another embodiment, a diode could be placed along the conductive element such that the stimulus or electrical current could only flow in one direction along the conductive element during the stimulation. This embodiment has several advantages, for example, it becomes possible to pace from some sites in the heart but not others by controlling which polarity of stimulus was generated by the implanted stimulus generator through its electrode(s). If two or more conductors are utilized, then the diode could be oriented in one direction for some of the electrodes and oriented in the opposite direction for other of the electrodes so that the first set of electrodes would pass current with one polarity while the other set would pass current of the other polarity. An additional set of conductors could contain no diode such that they would pass current with either polarity. The use of electrical components disposed along the conductive element increases the flexibility of stimulating of myocardium in different combinations and in different sequences.
  • Diodes may also be useful for delivering defibrillation and cardioversion shocks. A concern when delivering a shock through two or more electrodes that are of the same polarity and the same or nearly same strength, is that a region of little current flow and potential gradient will be created on the heart at the point somewhere between the common polarity electrodes. Creation of this low field region could significantly increase the defibrillation and cardioversion thresholds. Currently, most defibrillation shocks are biphasic with a second phase opposite in polarity to the first phase. The presence of the diode in one or more of the conductive elements would allow current to flow during one phase but not the other phase of the biphasic waveform. Therefore, the region of low field strength would only be present during one of the two phases of the shock so that the area could receive a stronger defibrillating field strength during the other phase.
  • In a further embodiment designed to avoid the region of low field strength throughout all phases of the shock, a capacitor is utilized instead of a diode along the length of the conductive element. The capacitor would allow current to flow during the early portion of the shock pulse thereby creating the low field strength region, but would not allow much current to flow later during the pulse, at which time the low field strength region would no longer be of the same strength and location. Towards the end of the shock pulse and after the shock pulse, the capacitor would discharge, creating a biphasic shock effect in some portions of the heart. If the shock pulse delivered from the defibrillator is, itself, biphasic, the second phase could be delivered either immediately after the first phase or after an interval of up to 5 ms or more since it has been shown that such a separation does not significantly decrease the beneficial effects of a biphasic pulse on defibrillation. Cooper et al. Pace, 16:471-482 (1993). Thus, with a short interval between the two phases of the shock, the capacitor would discharge during the second phase either partially or entirely followed by charging in the opposite polarity toward the end of the second phase. This interaction would change the ratio of the currents passing through the passive conductor assembly and through the active intravascular defibrillation electrodes throughout the pulses. Accordingly, the size and location of the low field regions should change throughout the pulses instead being fixed in one region. The movement of this low field strength region should have a beneficial effect on the defibrillation threshold.
  • Alternatively, the two active phases of the shock could be separated by up to 5 or more ms so that the capacitor will largely discharge between the two phases and following the second active phase.
  • Biphasic pulses are frequently used for pacing to prevent electrolysis and the plating or the unplating of the pacing electrodes that can occur with a single polarity pulse. Disposing a capacitor along the length of the conductor would generate a biphasic pacing pulse since it allows only a zero net charge to pass through the conductor after it has been discharged.
  • Other electronic components used in combination with the passive conductor assembly could be useful. These components could be powered by the current that passes through the conductive element when a stimulus is delivered through the active intravascular electrodes of the pacemaker or defibrillator. Electronic components could store the charge to power the other components disposed along the conductive element for some period of time following pulses delivered by the pacemaker or the defibrillator. The pulses to charge these electronic components could either be delivered whenever needed to treat or prevent arrhythmias or the pacemaker or defibrillator could deliver a small stimulus at specific time intervals for the sole purpose of charging the components disposed along the conductive element. This small stimulus could be of a frequency that does not stimulate the myocardium.
  • The electronic components that are powered along the conductive elements could perform several functions, for example, sensing activations at the ends or contacts on the conductive element. Pacing stimuli or shocks at these points along the conductive element could be time-based on the recorded activations from these electrodes. The timing algorithms could be performed by the electronic components disposed along the conductive element. Alternatively, the power in the conductive element could be used to pass a signal to the pacemaker or the defibrillator or its recording electrodes so that the software within the pacemaker or the defibrillator could control and integrate the responses of all of the passive conductors. Communication signals between the components disposed along the conductive element of the passive conductor and the pacemaker or the defibrillator could be by any modality including electrical or optical. If electrical, the frequency and strength of the signal could be such that the signal does not cause stimulation of the heart.
  • The passive conductor assembly is preferably oriented so that, during an electrical pulse delivered by the separated implanted stimulus generator, a potential difference is generated between the ends or other exposed regions (electrodes) of the conductive element disposed in the pericardial space. Typically, at least one of the electrodes will be placed on the epicardium overlying one of the implanted stimulus generator leads or electrodes located within the cavities of the heart or veins. However, other orientations may also be useful. For example, as reported in a study by Callihan et al., (JACC, 1995; 25:1373-1379), it was found that a passive patch electrode located distant from the defibrillation electrodes of an implanted cardioverter/defibrillator would transfer most of the potential gradient that would normally be present beneath this electrode to concentrate it at the edges of the electrode. For a small electrical stimulus, this effect may make it possible to pace from the edge of the electrode with an electrical stimulus that would not be strong enough to pace this region in the absence of the passive conductor.
  • As stated above, the present invention provides a method and device for the stimulation or the inhibition of neural inputs to the heart with the purpose of preventing atrial or ventricular arrhythmias, terminating atrial or ventricular arrhythmias, assisting in atrial or ventricular defibrillation, control of heart-rate variability, or the improvement of cardiac function. By adding the passive electrical components to the passive conductive element and modulating the frequency of stimulation of the intracavitary electrode therewith, the present invention allows for selective stimulation and/or inhibition of neural tissue and not cardiac tissue or vice versa through the same passive conductor assembly.
  • The device for the extra-cardiac stimulation or inhibition of neural inputs to the heart is similar if not identical to the device described immediately above. The uninsulated portions (electrodes) of at least one conductive element are disposed in contact with the heart and/or other tissues such as neural tissue, fat pads containing post-ganglionic neural fibers, cardiac veins adjacent to neural fibers, or other electrically excitable tissues such as the stellate ganglia and the vagus. The conductive element can also run circumferentially along the atrial-ventricular groove of the heart such that the sympathic and the parasymphatic innervation, running parallel to cardiac vasculature, can be directly stimulated or inhibited. Typically, the electrical stimulation or inhibition will be achieved with the application of stimuli from approximately 1 to 20 mA at a frequency of approximately 1 to 50 Hz. For neural stimulation, the stimulus could have a pulse width from approximately 10-250 μsec, a current of approximately 1-20 mA, and a frequency of approximately 1-50 Hz. For cardiac stimulation, the stimulus could have a pulse width from approximately 0.5-2 msec, a current of approximately 1-20 mA and a frequency of approximately 1-5 Hz.
  • The conductive element should be oriented such that when an electrical stimulus or pulse is delivered from the implanted stimulus generator, an electrical potential difference will be created on the epicardial surface between the two or more exposed electrodes on the conductive element. As a result of this potential difference, current will be induced to flow in the conductive element. To achieve a sufficient potential difference in the passive conductor assembly, at least one conductive element should be placed in close proximity to the cardiac tissue overlying either an intracavitary electrode in an atrial or ventricular chamber, cardiac vein, or other location in or near the heart.
  • Alternatively, the passive conductor assembly having at least one conductive element may be placed in the pericardial space, an extra-pericardial space, or in other extra-cardiac locations. The passive conductor assembly can be placed during surgery that exposes these locations directly or may be placed using minimally invasive techniques such as thoracoscopic surgery, or transvenously through an introducing catheter. Additionally, passive conductor assemblies for both neural stimulation/inhibition can be combined with passive conductor assemblies for directly exciting cardiac tissue.
  • The largest effect utilizing the passive conductor assembly of the present invention is generally seen when one end of the conductive element is placed directly on the epicardium over the intravenous electrode of the stimulus generating device. However, this does not have to be the case. In order to refine the placement of the passive conductor assembly, it may be helpful to map the regions of the heart that depolarize and hyperpolarize in the absence of the passive conductor assembly during a stimulus passed through the intravenous electrode. The implanted stimulus generator should cause hyperpolarization at one end and depolarization at the other. Accordingly, it should be possible to place the passive conductor assembly in a region that is normally undergoing depolarization induced by the stimulus. These two effects should be additive so that the amount of stimulus needed to directly stimulate the particular region or area of the heart should be lower than when the end of the conductive element that causes depolarization is placed in a region that is undergoing hyperpolarization caused by the electrical stimulus through the transvenously disposed electrodes. It is also possible that a similar beneficial effect might be seen if the end of the conductive element that causes hyperpolarization is placed in a region that is already undergoing hyperpolarization during the electrical stimulus.
  • As is stated above, more than one passive conductor assembly can be used in the same subject. For example, arrhythmias may be prevented by simultaneously stimulating from several sites on the heart. Two, three, or even more of the passive conductor assemblies could be placed in the pericardial space to pace from all of the sites. Even though the stimulus strength will be larger than if it was directly paced at each of the sites with electrodes connected directly to the implanted stimulus generator, the strength of the electrical stimulus should still be smaller than that required to directly activate all of these regions by a stimulus from the transvenous electrodes in the absence of the passive conductors of the present invention.
  • The passive conductor assembly of the present invention can be used for prevention and treatment of atrial-arrhythmias, ventricular arrhythmias, as well as for the control of cardiac performance through control of heart rate and atrial and ventricular refractory periods. Additionally, the passive conductor assembly can be used for the control of heart rate through stimulation of neural inputs to the sino-atrial and atrial-ventricular nodes of the heart.
  • Use of the passive conductor assembly of the present invention may be useful for augmenting traditional therapies such as antitachycardia pacing by altering the excitable gap through neural stimulation, thus improving the probability of pace termination of arrhythmias. Analogously, the passive conductor assembly and method for use thereof for neural stimulation may be beneficial for lowering the energy requirements for electrical termination of atrial or ventricular fibrillation. Neural stimulation can slow or even halt impulse propagation from the atria to the ventricles. Thus, the passive conductor assembly of the present invention should allow for control of the ventricular response to premature atrial contractions by slowing or stopping impulse propagation at the atrial-ventricular node. By causing transient heart block through neural stimulation, supra-ventricular arrhythmias such as Wolf-Parkinson-White Syndrome, atrial-ventricular nodal re-entrant tachycardia, atrial fibrillation or atrial flutter with rapid ventricular response and other arrhythmias may be successfully prevented, terminated, or controlled.
  • The utility of the compositions and methods according to the present invention are shown below in the Example section.
  • EXAMPLES
  • An example of the possible use of the passive conductor of the present invention is illustrated in FIG. 1. FIG. 1 illustrates the distribution of potentials generated with electrodes in the right ventricular cavity and on the skin of the left lower thorax. Even though the potential did change rapidly with distance in the lateral-apical left ventricle in the region marked A, signifying the potential gradient as low, the potential in this region for a 500V defibrillation shock was 83V more than the value on the epicardium overlying the electrode in the right ventricle in the region marked B [−48V−)−131 V)]. If a wire was attached to the epicardium at these spots, current should flow through the wire and the potential gradient should be increased in the lateral-apical left ventricle. This should allow stimulation of the tissue in the lateral-apical left ventricle region with a much weaker stimulus than required in the absence of the wire.
  • For example, in the preferred embodiment of the invention an electric wire 100 has one end 102 both electrically and mechanically attached to a preselected region 104 of the heart, e.g. by suturing. A second end 106 of the wire 100 is both electrically and mechanically connected to a different region 108 of the heart, also preferably by suturing. Since the heart regions 104 and 108 of the heart attain different electric potentials during cardiac contraction, current flows through the wire thus achieving passive stimulation of the myocardium.
  • The wire 100 is electrically insulated in any conventional fashion between its ends 102 and 106. However, one or more points of the wire 100 between its ends may be electrically connected to the heart to provide passive stimulation during cardiac contraction.
  • As another example, the area near the pulmonary veins appears to frequently play a role in the induction and/or maintenance of atrial fibrillation. This is also the region in which the effect of the shock is weakest for electrodes in the right atrium and the distal coronary sinus as shown by Cooper et al. (Herzschr Elektrophys, 1998; 9:1-7). It should be possible to run a conductor to this region by way of the transverse sinus in the pericardial space. Such an electrode location should be beneficial for pacing to prevent atrial fibrillation, for giving a small pacing or shocking stimulus or stimuli just as atrial fibrillation begins, or for giving a defibrillation shock to halt atrial fibrillation once it is established.
  • Other descriptive and exemplary materials are provided in Appendix A herewith.
  • In view of the teaching presented herein, other modifications and variations of the present inventions will be readily apparent to those of skill in the art. The foregoing drawings, discussion, and description are illustrative of some embodiments of the present invention, but are not meant to be limitations on the practice thereof. It is the following claims, including all equivalents, which define the scope of the invention.
  • Any patents or publications mentioned in this specification are indicative of the levels of those skilled in the art to which the invention pertains. These patents and publications are herein incorporated by reference to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference.

Claims (11)

1. A passive conductor assembly for use with an implanted stimulus generator having an intracavitarily disposed stimulating lead for stimulating the heart of a subject, said conductor assembly comprising:
at least one conductive element having at least two electrically conductive contacts for contacting a portion of the heart of the subject.
2. A conductor as set forth in claim 15, wherein said conductive element comprises an insulator disposed about at least a portion of said conductive element.
3. A conductor as set forth in claim 15, wherein said conductive element comprises a metallic wire.
4. A conductor as set forth in claim 15, wherein said conductive element comprises a metallic strip.
5. A conductor as set forth in claim 15, wherein said conductive element comprises a ribbon of conductive material.
6. A conductor as set forth in claim 15, wherein said conductive element includes at least one electrical component disposed in electrical communication therewith.
7. A conductor as set forth in claim 20, wherein said electrical component comprises a diode.
8. A conductor as set forth in claim 20, wherein said electrical component comprises a device capable of storing energy.
9. A conductor as set forth in claim 22, wherein said electrical component comprises a capacitor.
10. A conductor as set forth in claim 20, wherein said electrical component comprises a resistor.
11. A conductor as set forth in claim 20, wherein said electrical component comprises a microprocessor.
US11/391,604 1999-03-30 2006-03-28 Method and apparatus for passive cardiac stimulation Abandoned US20060178719A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/391,604 US20060178719A1 (en) 1999-03-30 2006-03-28 Method and apparatus for passive cardiac stimulation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12686799P 1999-03-30 1999-03-30
US10/019,873 US7020530B1 (en) 1999-03-30 2000-03-30 Method and apparatus for passive cardiac stimulation
PCT/US2000/008695 WO2000057950A1 (en) 1999-03-30 2000-03-30 Method and apparatus for passive cardiac stimulation
US11/391,604 US20060178719A1 (en) 1999-03-30 2006-03-28 Method and apparatus for passive cardiac stimulation

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2000/008695 Division WO2000057950A1 (en) 1999-03-30 2000-03-30 Method and apparatus for passive cardiac stimulation
US10/019,873 Division US7020530B1 (en) 1999-03-30 2000-03-30 Method and apparatus for passive cardiac stimulation

Publications (1)

Publication Number Publication Date
US20060178719A1 true US20060178719A1 (en) 2006-08-10

Family

ID=36084734

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/019,873 Expired - Fee Related US7020530B1 (en) 1999-03-30 2000-03-30 Method and apparatus for passive cardiac stimulation
US11/391,604 Abandoned US20060178719A1 (en) 1999-03-30 2006-03-28 Method and apparatus for passive cardiac stimulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/019,873 Expired - Fee Related US7020530B1 (en) 1999-03-30 2000-03-30 Method and apparatus for passive cardiac stimulation

Country Status (1)

Country Link
US (2) US7020530B1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080021505A1 (en) * 2006-07-21 2008-01-24 Roger Hastings Electrical stimulation of body tissue using interconnected electrode assemblies
US20080109054A1 (en) * 2004-10-20 2008-05-08 Scimed Life Systems, Inc. Leadless Cardiac Stimulation Systems
US20090080610A1 (en) * 2007-09-26 2009-03-26 Cyberheart, Inc. Radiosurgical Ablation of the Myocardium
US8185213B2 (en) 2006-07-21 2012-05-22 Boston Scientific Scimed, Inc. Delivery of cardiac stimulation devices
US8204605B2 (en) 2008-02-07 2012-06-19 Cardiac Pacemakers, Inc. Multi-site atrial electrostimulation
US8332036B2 (en) 2004-10-20 2012-12-11 Boston Scientific Scimed, Inc. Leadless cardiac stimulation systems
US8644934B2 (en) 2006-09-13 2014-02-04 Boston Scientific Scimed Inc. Cardiac stimulation using leadless electrode assemblies
US10022538B2 (en) 2005-12-09 2018-07-17 Boston Scientific Scimed, Inc. Cardiac stimulation system
US10583301B2 (en) 2016-11-08 2020-03-10 Cardiac Pacemakers, Inc. Implantable medical device for atrial deployment

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7908003B1 (en) * 1996-08-19 2011-03-15 Mr3 Medical Llc System and method for treating ischemia by improving cardiac efficiency
US20090005845A1 (en) * 2007-06-26 2009-01-01 Tamir Ben David Intra-Atrial parasympathetic stimulation
US8565896B2 (en) 2010-11-22 2013-10-22 Bio Control Medical (B.C.M.) Ltd. Electrode cuff with recesses
US8615294B2 (en) * 2008-08-13 2013-12-24 Bio Control Medical (B.C.M.) Ltd. Electrode devices for nerve stimulation and cardiac sensing
US8880192B2 (en) 2012-04-02 2014-11-04 Bio Control Medical (B.C.M.) Ltd. Electrode cuffs
US8718791B2 (en) 2003-05-23 2014-05-06 Bio Control Medical (B.C.M.) Ltd. Electrode cuffs
US20060004417A1 (en) * 2004-06-30 2006-01-05 Cvrx, Inc. Baroreflex activation for arrhythmia treatment
US8036739B2 (en) * 2006-10-13 2011-10-11 Cardiac Pacemakers, Inc. Electrical energy delivery tissue site validation
US7826899B1 (en) * 2006-12-22 2010-11-02 Pacesetter, Inc. Neurostimulation and neurosensing techniques to optimize atrial anti-tachycardia pacing for termination of atrial tachyarrhythmias
US7715915B1 (en) * 2006-12-22 2010-05-11 Pacesetter, Inc. Neurostimulation and neurosensing techniques to optimize atrial anti-tachycardia pacing for prevention of atrial tachyarrhythmias
US8233982B2 (en) 2007-02-21 2012-07-31 Cardiac Pacemakers, Inc. Systems and methods for treating supraventricular arrhythmias
US8406877B2 (en) * 2007-03-19 2013-03-26 Cardiac Pacemakers, Inc. Selective nerve stimulation with optionally closed-loop capabilities
US8676315B2 (en) 2011-07-26 2014-03-18 General Electric Company System and method of electrical current detection in electrophysiology study

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834100A (en) * 1986-05-12 1989-05-30 Charms Bernard L Apparatus and method of defibrillation
US5109842A (en) * 1990-09-24 1992-05-05 Siemens Pacesetter, Inc. Implantable tachyarrhythmia control system having a patch electrode with an integrated cardiac activity system
US5824030A (en) * 1995-12-21 1998-10-20 Pacesetter, Inc. Lead with inter-electrode spacing adjustment
US5968086A (en) * 1998-02-23 1999-10-19 Medtronic, Inc. Pacing and cardioversion lead systems with shared lead conductors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834100A (en) * 1986-05-12 1989-05-30 Charms Bernard L Apparatus and method of defibrillation
US5109842A (en) * 1990-09-24 1992-05-05 Siemens Pacesetter, Inc. Implantable tachyarrhythmia control system having a patch electrode with an integrated cardiac activity system
US5824030A (en) * 1995-12-21 1998-10-20 Pacesetter, Inc. Lead with inter-electrode spacing adjustment
US5968086A (en) * 1998-02-23 1999-10-19 Medtronic, Inc. Pacing and cardioversion lead systems with shared lead conductors

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10076658B2 (en) 2004-10-20 2018-09-18 Cardiac Pacemakers, Inc. Leadless cardiac stimulation systems
US9545513B2 (en) 2004-10-20 2017-01-17 Cardiac Pacemakers, Inc. Leadless cardiac stimulation systems
US10493288B2 (en) 2004-10-20 2019-12-03 Boston Scientific Scimed Inc. Leadless cardiac stimulation systems
US10850092B2 (en) 2004-10-20 2020-12-01 Boston Scientific Scimed, Inc. Leadless cardiac stimulation systems
US9925386B2 (en) 2004-10-20 2018-03-27 Cardiac Pacemakers, Inc. Leadless cardiac stimulation systems
US20080109054A1 (en) * 2004-10-20 2008-05-08 Scimed Life Systems, Inc. Leadless Cardiac Stimulation Systems
US10029092B2 (en) 2004-10-20 2018-07-24 Boston Scientific Scimed, Inc. Leadless cardiac stimulation systems
US9072911B2 (en) 2004-10-20 2015-07-07 Boston Scientific Scimed, Inc. Leadless cardiac stimulation systems
US8332036B2 (en) 2004-10-20 2012-12-11 Boston Scientific Scimed, Inc. Leadless cardiac stimulation systems
US8340780B2 (en) 2004-10-20 2012-12-25 Scimed Life Systems, Inc. Leadless cardiac stimulation systems
US8478408B2 (en) 2004-10-20 2013-07-02 Boston Scientific Scimed Inc. Leadless cardiac stimulation systems
US11154247B2 (en) 2005-12-09 2021-10-26 Boston Scientific Scimed, Inc. Cardiac stimulation system
US10022538B2 (en) 2005-12-09 2018-07-17 Boston Scientific Scimed, Inc. Cardiac stimulation system
US11766219B2 (en) 2005-12-09 2023-09-26 Boston Scientific Scimed, Inc. Cardiac stimulation system
US8290600B2 (en) * 2006-07-21 2012-10-16 Boston Scientific Scimed, Inc. Electrical stimulation of body tissue using interconnected electrode assemblies
US9308374B2 (en) 2006-07-21 2016-04-12 Boston Scientific Scimed, Inc. Delivery of cardiac stimulation devices
US9662487B2 (en) 2006-07-21 2017-05-30 Boston Scientific Scimed, Inc. Delivery of cardiac stimulation devices
US10426952B2 (en) 2006-07-21 2019-10-01 Boston Scientific Scimed, Inc. Delivery of cardiac stimulation devices
US20080021505A1 (en) * 2006-07-21 2008-01-24 Roger Hastings Electrical stimulation of body tissue using interconnected electrode assemblies
US8185213B2 (en) 2006-07-21 2012-05-22 Boston Scientific Scimed, Inc. Delivery of cardiac stimulation devices
US11338130B2 (en) 2006-07-21 2022-05-24 Boston Scientific Scimed, Inc. Delivery of cardiac stimulation devices
US8644934B2 (en) 2006-09-13 2014-02-04 Boston Scientific Scimed Inc. Cardiac stimulation using leadless electrode assemblies
US9956401B2 (en) 2006-09-13 2018-05-01 Boston Scientific Scimed, Inc. Cardiac stimulation using intravascularly-deliverable electrode assemblies
US8315691B2 (en) 2007-09-26 2012-11-20 Cyberheart, Inc. Radiosurgical ablation of the myocardium
US8805481B2 (en) 2007-09-26 2014-08-12 Cyberheart, Inc. Radiosurgical ablation of the myocardium
WO2009042842A1 (en) * 2007-09-26 2009-04-02 Cyberheart, Inc. Radiosurgical ablation of the myocardium
US20090080610A1 (en) * 2007-09-26 2009-03-26 Cyberheart, Inc. Radiosurgical Ablation of the Myocardium
US9795797B2 (en) 2008-02-07 2017-10-24 Cardiac Pacemakers, Inc. Wireless tissue electrostimulation
US10307604B2 (en) 2008-02-07 2019-06-04 Cardiac Pacemakers, Inc. Wireless tissue electrostimulation
US8738147B2 (en) 2008-02-07 2014-05-27 Cardiac Pacemakers, Inc. Wireless tissue electrostimulation
US8204605B2 (en) 2008-02-07 2012-06-19 Cardiac Pacemakers, Inc. Multi-site atrial electrostimulation
US9393405B2 (en) 2008-02-07 2016-07-19 Cardiac Pacemakers, Inc. Wireless tissue electrostimulation
US10583301B2 (en) 2016-11-08 2020-03-10 Cardiac Pacemakers, Inc. Implantable medical device for atrial deployment

Also Published As

Publication number Publication date
US7020530B1 (en) 2006-03-28

Similar Documents

Publication Publication Date Title
US20060178719A1 (en) Method and apparatus for passive cardiac stimulation
US8838238B2 (en) Ventricular pacing
US8718760B2 (en) Subcutaneous implantable cardioverter-defibrillator placement methods
US8644926B2 (en) Subcutaneous defibrillator implantation
EP0688579B1 (en) Device for heart therapy
US6157862A (en) Shaped multiple electrode lead for implantable device
US5683429A (en) Method and apparatus for cardiac pacing to prevent atrial fibrillation
US6327498B1 (en) Implantable stimulation lead for use with an ICD device having automatic capture pacing features
US20080086175A1 (en) Method and apparatus for reducing defibrillation threshold
EP0688577A1 (en) Device for treating atrial tachyarrhythmia
Nathan et al. Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias.
Scherlag et al. Endovascular neural stimulation via a novel basket electrode catheter: comparison of electrode configurations
US5383908A (en) Defibrillation system having innominate vein electrode and method for its use
EP0373953A2 (en) Endocardial defibrillation electrode system
US20190143118A1 (en) Leads and methods for cardiac resynchronization therapy
Goldberg Intra-SA-nodal pacemaker shifts induced by autonomic nerve stimulation in the dog
Furukawa et al. Chronotropic and dromotropic responses to stimulation of intracardiac sympathetic nerves to sinoatrial or atrioventricular nodal region in anesthetized dogs.
Furukawa et al. Differential intracardiac sympathetic and parasympathetic innervation to the SA and AV nodes in anesthetized dog hearts
WO2000057950A1 (en) Method and apparatus for passive cardiac stimulation
Schauerte et al. Transvascular Parasympathetic Stimulation for Ventricular Rate Control During Atrial Fibrillation: A Bionic Approach

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE UAB RESEARCH FOUNDATION, ALABAMA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:IDEKER, RAYMOND E.;GIROUARD, STEVEN D.;REEL/FRAME:017683/0101

Effective date: 19990419

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION